The main market opportunities in fibromyalgia therapeutics include the significant number of anticipated cases in India by 2029, a limited treatment landscape with few approved drugs and generics dominance, and untapped potential in early-stage clinical asset… For the full story, visit the source.
Science
Fibromyalgia Market Competitive Landscape Report 2026: Market is Not Likely to See Any Major Shifts in the Near Term, with No Products in Pre-registration or Phase III Development.
The main market opportunities in fibromyalgia therapeutics include the significant number of anticipated cases in India by 2029, a limited treatment landscape with few approved drugs and generics dominance, and untapped potential in early-stage clinical asset…
By Research and Markets· GlobeNewswire· 23 days ago· 2 min read
This summary is sourced from GlobeNewswire. Read the full article at:GlobeNewswire